Eli Lilly and Company, the pharmaceutical company that manufactures FDA-approved tirzepatide products, currently makes two medicines that contain tirzepatide
But GLP-1 drugs do not slow metabolism
Why Personalization Matters Every persons digestive system reacts differently to GLP-1 medications
it's about optimizing your body's ability to use nutrients, stimulate appetite, and build muscle
GLP-1 receptor activation suppresses appetite, slows gastric emptying, and enhances insulin secretion in a glucose-dependent manner
This blog post is for informational purposes only and does not constitute medical advice, diagnosis, or treatment